GoodRx Holdings, Inc. revenue by segment GDRX

GoodRx Holdings, Inc. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Prescription Transactions Revenue at $544.0 million, 68% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
785
797
792
750
767
745
551
Prescription Transactions Revenue
472
-18.2%
share 60.1%
544
-5.8%
share 68.3%
578
+4.9%
share 72.9%
551
+0.0%
share 73.4%
551
-7.2%
share 71.8%
593
+21.5%
share 79.6%
488
share 88.7%
Pharma Manufacturer Solutions Revenues
202
+68.2%
share 25.7%
151
share 19.0%
—
85
-14.4%
share 11.3%
99
+35.6%
share 13.0%
73
share 9.8%
—
Subscription Revenue
95
+14.1%
share 12.1%
84
-3.2%
share 10.5%
87
-8.3%
share 10.9%
94
-1.8%
share 12.6%
96
+60.5%
share 12.5%
60
+103.9%
share 8.0%
29
share 5.3%
Other Revenue
16
-14.9%
share 2.1%
18
-15.8%
share 2.2%
21
+4.7%
share 2.7%
20
-1.8%
share 2.7%
20
+8.7%
share 2.7%
19
-43.2%
share 2.5%
33
share 6.0%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Services-Computer Processing & Data Preparation (SIC 7374)
Listed as
GDRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Santa Monica, CA
SEC filer status
Accelerated filer
SEC CIK
1809519

Other Services-Computer Processing & Data Preparation companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.